UK markets open in 59 minutes
NIKKEI 225
26,780.20 -269.27 (-1.00%) HANG SENG
21,987.88 -431.09 (-1.92%) CRUDE OIL
111.34 -0.42 (-0.38%) GOLD FUTURES
1,822.90 +1.70 (+0.09%) DOW
30,946.99 -491.31 (-1.56%) BTC-GBP
16,542.97 -571.64 (-3.34%)
Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Loading interactive chart…
- Business Wire
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
NEW YORK, June 28, 2022--Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity and mortality. Priovant was established in September 2021 through a transaction between Roivant (Nasdaq: ROIV) and Pfizer (NYSE: PFE), in which Pfizer licensed oral and topical brepocitinib’s global development rights and US and Japan commercial rights to Priovant. Pfizer holds
- Yahoo Finance
States could ban abortion pill for Medicaid enrollees, experts say
States could sidestep FDA-approved abortion pills after the Supreme Court overturned Roe v. Wade. But it remains to be seen if the federal government can enforce access.
© 2022 Yahoo. All rights reserved.
